tiprankstipranks
Freeline Therapeutics Holdings (FRLN)
NASDAQ:FRLN
Holding FRLN?
Track your performance easily

Freeline Therapeutics Holdings (FRLN) Stock Investors

210 Followers
Based on 716,948 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold FRLN
On average, investors allocate 0.00% of their portfolios to FRLN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 716,948 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding FRLN

1.2%
Last 7
Days
4.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding FRLN, out of 716,948 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

FRLN Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 13,388 investors who made their portfolios public
The table shows changes in FRLN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

FRLN Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.20%
-0.03%
+6.18%
35.32B
Consumer Cyclical
Coherus Biosciences
2.64%
-1.10%
-3.76%
276.18M
Healthcare
ChargePoint Holdings
3.99%
-0.84%
-1.96%
806.79M
Consumer Cyclical
Marathon Digital Holdings
5.95%
+0.47%
+6.21%
5.10B
Financial
AMC Entertainment
5.38%
-0.67%
-2.39%
1.20B
Communication Services
Plug Power
4.85%
-0.24%
+2.75%
2.06B
Industrials
Trade Desk
4.79%
+0.71%
+5.20%
40.13B
Technology
Micron
5.26%
+0.65%
+4.68%
89.96B
Technology
Block
4.30%
+0.59%
+7.13%
39.59B
Technology
Li Auto
5.59%
+0.49%
+4.05%
33.18B
Consumer Cyclical
Based on the activity of 716,948 active portfolios
Open your Smart Portfolio

FRLN Investor Analysis

FRLN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.0%
of FRLN holders
are under 35
Average Segment Performance
Average P/E Ratio12.71
Beta7.27
Dividend Yield5.47%
FRLN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.0%
of FRLN holders
are between 35–55
Average Segment Performance
Average P/E Ratio9.96
Beta11.07
Dividend Yield5.92%
FRLN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
28.0%
of FRLN holders
are over 55
Average Segment Performance
Average P/E Ratio6.89
Beta5.88
Dividend Yield5.37%
Overview of age group and performance of FRLN stock investors
See who invests in FRLN according to age group and performance.

FAQ

How many retail Investors hold FRLN?
<0.1% of TipRanks' retail investors hold FRLN in their portfolios.
    What is FRLN Investor Sentiment?
    FRLN’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of FRLN in the last 7 days?
      ▼ 1.2% of TipRanks' retail investors changed their holding of FRLN in the last 7 days.
        What percentage of retail investors changed their holding of FRLN in the last 30 days?
        ▼ 4.0% of TipRanks' retail investors changed their holding of FRLN in the last 30 days.
          What is the average age of retail investors who hold FRLN?
          The average age of FRLN Holders is between 35–55.
            What other stocks have FRLN investors also bought?
            FRLN Investors also bought DKNG, CHRS, CHPT, MARA, AMC, PLUG, TTD, MU, SQ, LI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              CORCencora
              BSXBoston Scientific
              CAHCardinal Health
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis